Literature DB >> 35749515

FOXP3 exon 2 controls Treg stability and autoimmunity.

Jianguang Du1, Qun Wang1, Shuangshuang Yang1,2, Si Chen1,3, Yongyao Fu2, Sabine Spath4, Phillip Domeier4, David Hagin5,6,7, Stephanie Anover-Sombke5,6,7, Maya Haouili1, Sheng Liu8, Jun Wan8, Lei Han1, Juli Liu1, Lei Yang1, Neel Sangani9,10, Yujing Li8, Xiongbin Lu8, Sarath Chandra Janga8,9,10, Mark H Kaplan2, Troy R Torgerson5,6,7, Steven F Ziegler4, Baohua Zhou1,2.   

Abstract

Differing from the mouse Foxp3 gene that encodes only one protein product, human FOXP3 encodes two major isoforms through alternative splicing-a longer isoform (FOXP3 FL) containing all the coding exons and a shorter isoform lacking the amino acids encoded by exon 2 (FOXP3 ΔE2). The two isoforms are naturally expressed in humans, yet their differences in controlling regulatory T cell phenotype and functionality remain unclear. In this study, we show that patients expressing only the shorter isoform fail to maintain self-tolerance and develop immunodeficiency, polyendocrinopathy, and enteropathy X-linked (IPEX) syndrome. Mice with Foxp3 exon 2 deletion have excessive follicular helper T (TFH) and germinal center B (GC B) cell responses, and develop systemic autoimmune disease with anti-dsDNA and antinuclear autoantibody production, as well as immune complex glomerulonephritis. Despite having normal suppressive function in in vitro assays, regulatory T cells expressing FOXP3 ΔE2 are unstable and sufficient to induce autoimmunity when transferred into Tcrb-deficient mice. Mechanistically, the FOXP3 ΔE2 isoform allows increased expression of selected cytokines, but decreased expression of a set of positive regulators of Foxp3 without altered binding to these gene loci. These findings uncover indispensable functions of the FOXP3 exon 2 region, highlighting a role in regulating a transcriptional program that maintains Treg stability and immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35749515      PMCID: PMC9333337          DOI: 10.1126/sciimmunol.abo5407

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  57 in total

1.  The FOXP3Δ2 isoform supports Treg cell development and protects against severe IPEX syndrome.

Authors:  Katie Frith; Anne-Laure Joly; Cindy S Ma; Stuart G Tangye; Zuzana Lohse; Christina Seitz; Charles F Verge; John Andersson; Paul Gray
Journal:  J Allergy Clin Immunol       Date:  2019-03-21       Impact factor: 10.793

2.  An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.

Authors:  Chie Miyabe; Yoshishige Miyabe; Klemen Strle; Nancy D Kim; John H Stone; Andrew D Luster; Sebastian Unizony
Journal:  Ann Rheum Dis       Date:  2016-12-07       Impact factor: 19.103

3.  Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3.

Authors:  Ichiro Kobayashi; Mitsuru Kubota; Masafumi Yamada; Hiroshi Tanaka; Shuichi Itoh; Yoji Sasahara; Luke Whitesell; Tadashi Ariga
Journal:  Clin Immunol       Date:  2011-06-13       Impact factor: 3.969

4.  The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells.

Authors:  Wook-Jin Chae; Octavian Henegariu; Sang-Kyou Lee; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

5.  Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX).

Authors:  I Kobayashi; R Shiari; M Yamada; N Kawamura; M Okano; A Yara; A Iguchi; N Ishikawa; T Ariga; Y Sakiyama; H D Ochs; K Kobayashi
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

6.  A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.

Authors:  Frédéric Van Gool; Michelle L T Nguyen; Maxwell R Mumbach; Ansuman T Satpathy; Wendy L Rosenthal; Simone Giacometti; Duy T Le; Weihong Liu; Todd M Brusko; Mark S Anderson; Alexander Y Rudensky; Alexander Marson; Howard Y Chang; Jeffrey A Bluestone
Journal:  Immunity       Date:  2019-01-29       Impact factor: 31.745

Review 7.  Therapies for allergic inflammation: refining strategies to induce tolerance.

Authors:  Cezmi A Akdis
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

8.  CRISPR screen in regulatory T cells reveals modulators of Foxp3.

Authors:  Jessica T Cortez; Elena Montauti; Eric Shifrut; Jovylyn Gatchalian; Yusi Zhang; Oren Shaked; Yuanming Xu; Theodore L Roth; Dimitre R Simeonov; Yana Zhang; Siqi Chen; Zhongmei Li; Jonathan M Woo; Josephine Ho; Ian A Vogel; Grace Y Prator; Bin Zhang; Youjin Lee; Zhaolin Sun; Igal Ifergan; Frédéric Van Gool; Diana C Hargreaves; Jeffrey A Bluestone; Alexander Marson; Deyu Fang
Journal:  Nature       Date:  2020-04-29       Impact factor: 49.962

9.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

10.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.

Authors:  Reiner K W Mailer; Anne-Laure Joly; Sang Liu; Szabolcs Elias; Jesper Tegner; John Andersson
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

View more
  1 in total

Review 1.  The Role of FOXP3 on Tumor Metastasis and Its Interaction with Traditional Chinese Medicine.

Authors:  Benxu Ma; Wenjun Miao; Jieqiong Xiao; Xinyi Chen; Jing Xu; Yinan Li
Journal:  Molecules       Date:  2022-10-08       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.